Pragma Bio
Focus: Pragma Bio is a San Francisco-based biotechnology company specializing in microbial-derived small molecules for oncology. Scale and detailed market position remain unclear from available data.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Pragma Bio
AI assessmentNot HiringNo open roles listed right now. Follow Pragma Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthWatch
Pipeline
Early-stage
0 total
LOE Risk
1 imminent
MOXATAG
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
LOE Approaching2.8yr
Owned asset with patent expiration in 2029; not a core oncology focus and unlikely to drive company strategy.
Help build intelligence for Pragma Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.